MC2262A1 - Composes antibacteriens - Google Patents

Composes antibacteriens

Info

Publication number
MC2262A1
MC2262A1 MC932182A MC2182A MC2262A1 MC 2262 A1 MC2262 A1 MC 2262A1 MC 932182 A MC932182 A MC 932182A MC 2182 A MC2182 A MC 2182A MC 2262 A1 MC2262 A1 MC 2262A1
Authority
MC
Monaco
Prior art keywords
hydrogen
group
oxo
methyl
piperazinyl
Prior art date
Application number
MC932182A
Other languages
English (en)
French (fr)
Inventor
Louis Dax Scott
Dalton Keith Dennis
Loreen Rossman Pamela
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2262A1 publication Critical patent/MC2262A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MC932182A 1990-04-09 1991-04-05 Composes antibacteriens MC2262A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50613590A 1990-04-09 1990-04-09

Publications (1)

Publication Number Publication Date
MC2262A1 true MC2262A1 (fr) 1993-04-26

Family

ID=24013339

Family Applications (1)

Application Number Title Priority Date Filing Date
MC932182A MC2262A1 (fr) 1990-04-09 1991-04-05 Composes antibacteriens

Country Status (17)

Country Link
EP (1) EP0451764A1 (2)
JP (1) JPH04234884A (2)
AU (1) AU7420591A (2)
BR (1) BR9101418A (2)
CA (1) CA2039987A1 (2)
CS (1) CS94391A2 (2)
FI (1) FI911666A7 (2)
HU (1) HUT57769A (2)
IE (1) IE911161A1 (2)
IL (1) IL97797A0 (2)
MC (1) MC2262A1 (2)
MX (1) MX25231A (2)
NO (1) NO911357L (2)
PT (1) PT97287A (2)
TW (1) TW216420B (2)
YU (1) YU62991A (2)
ZA (1) ZA912279B (2)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
KR100204987B1 (ko) * 1990-04-18 1999-06-15 제이코버스 코넬리스 레이서 항미생물성 퀴놀로닐 락탐
ES2101119T3 (es) * 1991-10-01 1997-07-01 Procter & Gamble Pharma Procedimiento para preparar quinolonil-lactamas antimicrobianas.
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
DE4234330A1 (de) * 1992-10-12 1994-04-14 Bayer Ag Chinoloncarbonsäuren
FI970427A7 (fi) * 1994-08-02 1997-03-26 Procter & Gamble Menetelmä mikrobinvastaisten yhdisteiden valmistamiseksi
NZ290722A (en) * 1994-08-02 1999-03-29 Procter & Gamble A process for making derivatives of quinolonyl lactam (qla's); intermediates
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
US5973142A (en) * 1997-01-21 1999-10-26 Yasuda; Nobuyoshi Process for synthesizing carbapenem intermediates
EP0971889B1 (en) * 1997-01-21 2003-08-13 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
US6080854A (en) * 1997-08-25 2000-06-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1179675A (en) * 1981-01-30 1984-12-18 Erwin Gotschi 7-oxo-1-azabicyclo ¬3,2,0| heptene-2-derivatives
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
EP0366193A3 (en) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial quinolonyl lactams
DE68929227T2 (de) * 1988-10-24 2001-05-31 Procter & Gamble Pharmaceuticals, Inc. Antimikrobielle Quinolonyllactamester
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones

Also Published As

Publication number Publication date
IE911161A1 (en) 1991-10-09
HUT57769A (en) 1991-12-30
AU7420591A (en) 1991-10-10
ZA912279B (en) 1992-02-26
FI911666A0 (fi) 1991-04-08
NO911357D0 (no) 1991-04-08
YU62991A (sh) 1994-04-05
IL97797A0 (en) 1992-06-21
CA2039987A1 (en) 1991-10-10
MX25231A (es) 1993-10-01
FI911666A7 (fi) 1991-10-10
PT97287A (pt) 1992-01-31
EP0451764A1 (en) 1991-10-16
JPH04234884A (ja) 1992-08-24
CS94391A2 (en) 1991-11-12
NO911357L (no) 1991-10-10
BR9101418A (pt) 1991-11-26
HU911132D0 (en) 1991-10-28
TW216420B (2) 1993-11-21

Similar Documents

Publication Publication Date Title
MC2262A1 (fr) Composes antibacteriens
FR2511678A1 (fr) Derives de carbapeneme, leur procede de preparation et leur application en therapeutique
MC1921A1 (fr) Derives acyles
DK161832B (da) Analogifremgangsmaade til fremstilling af 1-sulfo-2-azetidinonderivater eller farmaceutisk acceptable salte eller estere deraf
CN1060093A (zh) 1-甲基碳杂青霉烯衍生物及其制备方法
FR2528847A1 (fr) Produits nouveaux de la classe des carbapenems et leur application en tant qu'antibiotiques
SE466451B (sv) Estrar av (6r,7r)-3-karbomoyloximetyl-7-/ (z)-2-(fur-2-yl)-2-metoxi-iminoacetamido /cef-3-em-4-karboxylsyra
US4537886A (en) β-lactam antibacterial agents and compositions containing them
FR2524890A1 (fr) Nouveaux derives de carbapenem, compositions pharmaceutiques les contenant, composes intermediaires pour leur preparation, et leurs procedes de production
CH628900A5 (fr) Procede de preparation de thio-oximes derivees de cephalosporines et de penicillines.
FR2542316A1 (fr) Procede de preparation de derives carbapenem, nouveaux intermediaires de synthese et procede de preparation de ces intermediaires
JPH0217557B2 (2)
IE63026B1 (en) Stable oxapenem-3-carboxylic acids
FI89490B (fi) Foerfarande foer framstaellning av 2-metoximetyl-penemderivat
US5028427A (en) "Cephalosporin" compounds
FR2499081A1 (fr) Derives de 7-oxo-1-azabicyclo (3-2-0) hept-2-ene, leur preparation et leur application en tant que medicaments
BE848545A (fr) Derives n-methylene substitues de thienamycine,
FR2583417A1 (fr) Acides 3-acylamino-2-oxo-1-azetidinesulfoniques a action therapeutique.
EP0362622B1 (de) Verwendung stabiler Oxapenem-3-carbonsäuren zur Herstellung Beta-Lactamase hemmender Arzneimittel
US4678782A (en) 3S-formamido azetidinone antibacterial agents, their preparation and use
BE897854A (fr) Derives de carbapeneme antibiotiques
JPH07503460A (ja) ２−イソセフェムおよびオキサセファム誘導体，それらの製法，その中間体および抗菌剤としての使用
JPS61176563A (ja) ４，４‐ジアルキル‐２‐アゼチジノン類の製造法
FR2696179A1 (fr) Dérivés de thioalkylthiocarbacéphalosporine, procédé pour leurs préparations et formulation pharmaceutique les contenant pour le traitement ou la prophylaxie des infections bactériennes.
FR2534253A1 (fr) Acide azetidinyl sulfonique et analogues, a action therapeutique